Scientists Find Brain Inflammation Switch for Alzheimer's

Scientists at Scripps Research just found a way to flip the off switch on brain inflammation that destroys connections in Alzheimer's patients.

The discovery centers on a protein called STING that normally helps the brain's immune system fight threats. In Alzheimer's, this protein gets stuck in overdrive after undergoing a chemical change, triggering the kind of chronic inflammation that damages the connections between brain cells where memories live.

Dr. Stuart Lipton and his team identified the exact spot on STING where this harmful change occurs. They found elevated levels of the overactive protein in brain tissue from Alzheimer's patients, in lab-grown human brain cells, and in mice with the disease.

Here's where it gets exciting. The researchers created a modified version of STING that can't get stuck in overdrive. When they tested it in mice with Alzheimer's, brain inflammation dropped significantly and the connections between nerve cells stayed protected.

Those connections, called synapses, are exactly what Alzheimer's destroys as it steals memories and thinking ability. Protecting them is one of the most important goals in dementia research.

The team also discovered that signature Alzheimer's protein clumps can directly trigger the STING overactivation, creating a vicious cycle. Protein buildup sparks inflammation, which produces molecules that jam STING into its destructive mode, which amplifies inflammation even more.

The Bright Side

What makes this discovery particularly promising is its precision. Unlike treatments that shut down the entire immune response and leave patients vulnerable to infection, this approach only stops STING from becoming overactive. The protein can still do its normal job of protecting against viruses and bacteria.

Lipton, who is both a researcher and a clinical neurologist, has been studying this type of chemical change for more than 30 years. His lab previously linked it to aging, air pollution exposure, and diseases including Parkinson's and cancer. Now they're zeroing in on how it specifically damages the brain in Alzheimer's.

The research team is currently developing small molecules designed to block the exact site where STING goes haywire. These potential drugs will move into preclinical testing soon.

For the more than 6 million Americans living with Alzheimer's and their families, this research offers something beyond hope: it provides a clear target and a roadmap for protecting the brain connections that hold our memories and identity.